ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,710.48
-0.81%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Haemonetics Corp (HAE)

  7. Haemonetics Corp (HAE) Noticias

HAE

Haemonetics (HAE)

Haemonetics Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:HAE
FechaHoraFuenteTítuloSímboloCompañía
23/05/202405:03Edgar (US Regulatory)Form 8-K - Current reportNYSE:HAEHaemonetics Corp
23/05/202405:00PR Newswire (US)Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior NotesNYSE:HAEHaemonetics Corp
22/05/202405:37IH Market NewsNvidia Profits Set to Challenge Historic High Market; GE Aerospace Announces New Hires, and More NewsNYSE:HAEHaemonetics Corp
21/05/202417:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:HAEHaemonetics Corp
21/05/202415:05PR Newswire (US)Haemonetics Announces Proposed Convertible Senior Notes OfferingNYSE:HAEHaemonetics Corp
20/05/202410:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:HAEHaemonetics Corp
20/05/202405:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:HAEHaemonetics Corp
09/05/202405:00PR Newswire (US)Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations WebsiteNYSE:HAEHaemonetics Corp
10/04/202415:58PR Newswire (US)Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024NYSE:HAEHaemonetics Corp
04/04/202405:30PR Newswire (US)Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN CartridgeNYSE:HAEHaemonetics Corp
01/04/202407:00PR Newswire (US)Haemonetics Corporation Completes Acquisition of Attune MedicalNYSE:HAEHaemonetics Corp
05/03/202405:00PR Newswire (US)Haemonetics Announces Definitive Agreement to Acquire Attune MedicalNYSE:HAEHaemonetics Corp
21/02/202416:57PR Newswire (US)Haemonetics to Present at Raymond James 45th Annual Institutional Investors ConferenceNYSE:HAEHaemonetics Corp
21/02/202416:55PR Newswire (US)Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access DayNYSE:HAEHaemonetics Corp
13/02/202414:28Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:HAEHaemonetics Corp
08/02/202405:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:HAEHaemonetics Corp
08/02/202405:00PR Newswire (US)Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations WebsiteNYSE:HAEHaemonetics Corp
11/01/202415:05PR Newswire (US)Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024NYSE:HAEHaemonetics Corp
12/12/202305:00PR Newswire (US)Haemonetics Corporation Completes Acquisition of OpSens Inc.NYSE:HAEHaemonetics Corp
07/12/202315:05PR Newswire (US)Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:HAEHaemonetics Corp
02/11/202306:00PR Newswire (Canada)OPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE CIRCULAIRE DE SOLLICITATION DE PROCURATIONS RELATIVEMENT À L'ASSEMBLÉE EXTRAORDINAIRE DES ACTIONNAIRESNYSE:HAEHaemonetics Corp
02/11/202306:00PR Newswire (Canada)OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERSNYSE:HAEHaemonetics Corp
02/11/202305:00PR Newswire (US)Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations WebsiteNYSE:HAEHaemonetics Corp
12/10/202305:10Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:HAEHaemonetics Corp
10/10/202305:00PR Newswire (US)Haemonetics Corporation Announces Definitive Agreement to Acquire OpSens, Inc.NYSE:HAEHaemonetics Corp
10/10/202305:00PR Newswire (Canada)OPSENS SIGNE UNE CONVENTION DÉFINITIVE VISANT SON ACQUISITION PAR HAEMONETICSNYSE:HAEHaemonetics Corp
10/10/202305:00PR Newswire (Canada)OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICSNYSE:HAEHaemonetics Corp
05/10/202315:05PR Newswire (US)Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023NYSE:HAEHaemonetics Corp
29/08/202305:30PR Newswire (US)Haemonetics Announces European Expansion for VASCADE® Vascular Closure SystemNYSE:HAEHaemonetics Corp
11/08/202315:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:HAEHaemonetics Corp
 Showing the most relevant articles for your search:NYSE:HAE

Su Consulta Reciente

NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
USOTC
BASFY
BASF (QX)
COIN
SOLUSD
Solana
FX
EURUSD
Euro vs US Dollar
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AMZN
Amazon.com
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
CCOM
SILVER
SILVER
AMEX
SPY
SPDR S&P 500
FX
EURMXN
Euro vs MXN
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados